default author photo

Trevor J. Pugh

University Health Network - Tumor Immunotherapy Program

Toronto, Ontario

Canada

SCHOLARLY PAPERS

3

DOWNLOADS

120

TOTAL CITATIONS

0

Scholarly Papers (3)

1.

Microbiome-Driven Tryptophan Metabolism Suppresses Immunity in the Pancreatic Tumor Microenvironment by Activation of the Aryl Hydrocarbon Receptor

Number of pages: 68 Posted: 16 Apr 2021
University Health Network - Tumor Immunotherapy Program, University Health Network - Tumor Immunotherapy Program, Helmholtz Centre for Infection Research - Department of Computational Biology of Infection Research, University Health Network - Tumor Immunotherapy Program, University Health Network - Tumor Immunotherapy Program, University Health Network - Tumor Immunotherapy Program, University Health Network - Stem Cell Program, The University of Toronto - Department of Immunology, The University of Toronto - Department of Molecular Genetics, The University of Toronto - Department of Immunology, The University of Toronto - Department of Immunology, University Health Network - Tumor Immunotherapy Program, The University of Toronto - Department of Immunology, University Health Network - Tumor Immunotherapy Program, Human Health Therapeutics Research Centre, The University of Toronto - Department of Chemical Engineering and Applied Chemistry, The University of Toronto - Department of Chemical Engineering and Applied Chemistry, Ontario Institute for Cancer Research - PanCuRx Translational Research Initiative, Helmholtz Centre for Infection Research - Department of Computational Biology of Infection Research, University Health Network - Tumor Immunotherapy Program, The Ontario Institute for Cancer Research, Ontario Institute for Cancer Research - PanCuRx Translational Research Initiative, The University of Toronto - Department of Molecular Genetics, Ronin Institute, The University of Toronto - Department of Immunology, University Health Network - Tumor Immunotherapy Program and University Health Network - Tumor Immunotherapy Program
Downloads 54 (1,020,567)

Abstract:

Loading...

2.

A Phase Ii, Open-Label, Randomized Trial of Durvalumab with Olaparib or Cediranib in Patients with Mismatch Repair–Proficient Colorectal or Pancreatic Cancer

Number of pages: 54 Posted: 14 Mar 2024
Vall d’Hebron Institute of Oncology (VHIO), University of Toronto - Princess Margaret Cancer Centre, University of Toronto - Princess Margaret Cancer Centre, University of Toronto - Princess Margaret Cancer Centre, University of Toronto - Princess Margaret Cancer Centre, Vall d’Hebron Institute of Oncology (VHIO), University of Toronto - Princess Margaret Cancer Centre, University of Toronto - Princess Margaret Cancer Centre, University Health Network - Princess Margaret Cancer Centre, Vall d’Hebron Institute of Oncology (VHIO), Ontario Institute for Cancer Research, Ontario Institute for Cancer Research, University of Toronto - Princess Margaret Cancer Centre, University of Toronto - Princess Margaret Cancer Centre, University Health Network - Princess Margaret Bioinformatics and Computational Genomics Laboratory, Vall d’Hebron Institute of Oncology (VHIO), University of Toronto - Princess Margaret Cancer Centre, University of Toronto - Princess Margaret Cancer Centre, University Health Network - Tumor Immunotherapy Program, University of Toronto - Princess Margaret Cancer Centre, University of Toronto - Princess Margaret Cancer Centre and University of Toronto - Princess Margaret Cancer Centre
Downloads 43 (1,157,785)

Abstract:

Loading...

Immunotherapy, biomarkers, colorectal, pancreatic, cancer, cold tumors

3.

Prognostic value of perioperative circulating tumor DNA in endometrial cancer: systematic review & meta-analysis

Number of pages: 18 Posted: 05 Nov 2025
affiliation not provided to SSRN, University of Toronto, affiliation not provided to SSRN, University of Toronto - University Health Network, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, University Health Network - Tumor Immunotherapy Program, affiliation not provided to SSRN, University of Toronto - University Health Network, University of Toronto, affiliation not provided to SSRN, Vancouver Coastal Health, Vancouver Coastal Health, The Norwegian Radium Hospital Montebello and affiliation not provided to SSRN
Downloads 23 (1,411,822)

Abstract:

Loading...

endometrial cancer, circulating tumour DNA, tumour biomarker